Potato chip companies forced to reduce levels of cancer causing chemical in their products

NewsGuard 100/100 Score

Four American food manufacturers, who were taken to court because their products contained high levels of a cancer causing chemical, have reached a settlement with the state of California.

The four potato chip and french fry companies have agreed to reduce the levels of a cancer-causing chemical in their products and pay a combined $3 million in fines.

Heinz, Frito-Lay, Kettle Foods and Lance Inc. along with McDonald's, Burger King, KFC, and Wendy's, were found to have high levels of acrylamide in their potato chips and french fries.

Acrylamide is a byproduct of frying, roasting and baking foods, particularly potatoes, that contain certain amino acids. A study in 2002 by Swedish scientists discovered high levels of the chemical in fried potato products.

The lawsuits were filed under a state law that requires companies to post warnings about carcinogens in their products.

Attorney general Jerry Brown says getting the companies to agree to reduce the carcinogenic chemical in fried potatoes is a victory for public health and safety in California and other companies should follow suit.

The chains agreed last year to publish acrylamide warnings at their restaurants and pay civil penalties and costs and early this year Procter & Gamble agreed to cut acrylamide in Pringles potato chips by 50 percent.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels